Detalhe da pesquisa
1.
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer
; 23(1): 1080, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946136
2.
Biliary tract cancers have distinct epidemiological patterns and clinical characteristics according to tumour site.
HPB (Oxford)
; 25(6): 693-703, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958986
3.
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers.
Breast Cancer Res
; 24(1): 80, 2022 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401316
4.
Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer
; 202: 114037, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554542
5.
Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
Cancer Med
; 13(9): e7168, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733172
6.
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.
Breast
; 68: 149-156, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773403
7.
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
Cancers (Basel)
; 15(4)2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831640
8.
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.
Front Oncol
; 13: 1309890, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273853
9.
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Breast Cancer
; 30(6): 997-1007, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561255
10.
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
J Gastrointest Oncol
; 14(2): 997-1007, 2023 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37201091
11.
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Cancer Chemother Pharmacol
; 89(2): 197-208, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997290
12.
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing.
NPJ Breast Cancer
; 8(1): 28, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35246547
13.
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Eur J Cancer
; 165: 13-24, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189537
14.
Population Pharmacokinetics of Palbociclib in aReal-World Situation.
Pharmaceuticals (Basel)
; 14(3)2021 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668400
15.
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer.
Cancers (Basel)
; 13(21)2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771635
16.
Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients.
Pharmaceutics
; 13(10)2021 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34684001
17.
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program.
Breast
; 56: 18-25, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33561617
18.
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Eur J Cancer
; 148: 359-370, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780664
19.
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.
Pharmaceuticals (Basel)
; 13(11)2020 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238487
20.
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX.
Anticancer Res
; 40(7): 4011-4015, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620645